Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

SGP

SpyGlass Pharma Inc

Feb 12 • 04:00PM ET

27.50

-0.05 -0.18 %

Healthcare • Biotechnology • USA • NASD

Index	-	P/E	-	EPS (ttm)	-	Insider Own	49.88%	Shs Outstand	31.91M	Perf Week	-
Market Cap	877.80M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	16.00M	Perf Month	-
Enterprise Value	937.98M	PEG	-	EPS next Q	-	Inst Own	13.57%	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	4.17%
Book/sh	-1.90	P/C	53.95	EPS next 5Y	-	ROE	-	52W High	32.44 -15.23%	Perf Year	-
Cash/sh	0.51	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	20.16 36.41%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	4.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.23	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.23	EPS Q/Q	-	SMA20	1.51%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.32	Sales Q/Q	-	SMA50	1.51%	Rel Volume	0.17	Prev Close	27.55
Employees	-	LT Debt/Eq	0.29	Earnings	-	SMA200	1.51%	Avg Volume	386.89K	Price	27.50
IPO	Feb 06, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	64,308	Change	-0.18%

Feb-09-26 04:05PM

SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

(GlobeNewswire) +6.30%

SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RA CAPITAL MANAGEMENT, L.P.	Director	Feb 09 '26	Buy	16.00	3,690,000	59,040,000	5,966,439	Feb 11 05:15 PM
Behbahani Ali	Director	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Florence Anthony A. Jr.	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
BASKETT FOREST	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
New Enterprise Associates 17,	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Yang Rick	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Makhzoumi Mohamad	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
SANDELL SCOTT D	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Chang Carmen	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Walker Paul Edward	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Mathers Edward T	10% Owner	Feb 09 '26	Buy	16.00	937,500	15,000,000	6,035,038	Feb 11 04:30 PM
Pardo Geoffrey B	Director	Feb 09 '26	Buy	16.00	312,500	5,000,000	2,187,513	Feb 11 04:09 PM
Khan Bilal Arshad	Director	Feb 09 '26	Buy	16.00	115,000	1,840,000	251,427	Feb 11 04:07 PM
Khan Bilal Arshad	Director	Feb 09 '26	Buy	16.00	20,000	320,000	25,450	Feb 11 04:07 PM
Nielsen Kirk G.	Director	Feb 09 '26	Buy	16.00	165,000	2,640,000	3,310,619	Feb 10 06:09 PM
Vensana Capital I GP, LLC	10% Owner	Feb 09 '26	Buy	16.00	165,000	2,640,000	3,310,619	Feb 10 06:08 PM

Open in Screener

SI

Shoulder Innovations Inc

Feb 12 • 04:00PM ET

13.72

+1.47 12.00 %

Healthcare • Medical Devices • USA • NYSE

SI Shoulder Innovations Inc daily Stock Chart

Held by: VTI IWM VXF IWO VTWO IWC IWN VTWG RSSL VTWV

Index	RUT	P/E	-	EPS (ttm)	-1.79	Insider Own	52.73%	Shs Outstand	20.58M	Perf Week	9.15%
Market Cap	282.65M	Forward P/E	-	EPS next Y	-	Insider Trans	0.17%	Shs Float	9.74M	Perf Month	0.88%
Enterprise Value	160.28M	PEG	-	EPS next Q	-0.39	Inst Own	33.57%	Short Float	3.11%	Perf Quarter	20.77%
Income	-36.38M	P/S	6.79	EPS this Y	-	Inst Trans	68.97%	Short Ratio	4.81	Perf Half Y	4.41%
Sales	41.63M	P/B	1.91	EPS next Y	-	ROA	-32.08%	Short Interest	0.30M	Perf YTD	-4.06%
Book/sh	7.18	P/C	2.06	EPS next 5Y	-	ROE	-57.29%	52W High	17.94 -23.52%	Perf Year	-
Cash/sh	6.66	P/FCF	-	EPS past 3/5Y	- -	ROIC	-22.36%	52W Low	10.92 25.64%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	76.67%	Volatility	9.73% 7.17%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.85	EPS Y/Y TTM	-148.57%	Oper. Margin	-51.25%	ATR (14)	0.99	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.80	Sales Y/Y TTM	39.97%	Profit Margin	-87.39%	RSI (14)	49.51	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.09	EPS Q/Q	-108.35%	SMA20	-0.44%	Beta	-	Target Price	20.60
Payout	-	Debt/Eq	0.10	Sales Q/Q	57.71%	SMA50	-4.88%	Rel Volume	2.45	Prev Close	12.25
Employees	56	LT Debt/Eq	0.10	Earnings	Nov 11 AMC	SMA200	-0.63%	Avg Volume	62.87K	Price	13.72
IPO	Jul 31, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	-104.21% 19.10%	Trades		Volume	153,774	Change	12.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-25-25	Initiated	Piper Sandler	Overweight	$18
Aug-25-25	Initiated	Jefferies	Buy	$19
Aug-25-25	Initiated	Goldman	Buy	$20
Aug-25-25	Initiated	BTIG Research	Buy	$23

Feb-05-26 10:49AM	Billionaire Chinese trader bets on silver collapse with $300 million wager (Investing.com)
03:28AM	Pandora shares rise as jeweller plans shift to platinum amid silver challenges (Investing.com)
Feb-03-26 04:05PM	Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (PR Newswire) -6.04%
Feb-02-26 08:00AM	Silver price shifts have not been seen in almost half a century, UBS says (Investing.com)
Jan-20-26 09:20AM	BCA cautions against chasing silver prices higher. Heres why (Investing.com)
09:58AM	Loading…
Dec-31-25 09:58AM	TSX flat as precious metals retreat on final trading day of 2025 (Investing.com) -5.61%
Dec-30-25 04:39PM	Insiders Made Their Bets in 2025-These Were the Top 5 Stocks They Bought (MarketBeat)
11:28AM	TSX higher as mining shares rebound on gold and silver recovery (Investing.com)
Dec-29-25 07:28AM	DigitalBridge and Coupang rise in premarket; Silver mining stocks fall (Investing.com)
Dec-24-25 07:26AM	Precious metals rally: UBS warns of profit-taking risk into holidays (Investing.com)
Dec-23-25 09:28AM	TSX gains on precious metals rally despite October GDP contraction (Investing.com)
Dec-03-25 07:00AM	Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty (PR Newswire)
Nov-19-25 04:05PM	Shoulder Innovations to Participate in the Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
Nov-12-25 02:35PM	Why Shoulder Innovations Stock Is Skyrocketing Today (Motley Fool) +32.04%
Nov-11-25 04:05PM	Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance (PR Newswire)
05:07PM	Loading…
Nov-06-25 05:07PM	A-Mark reports Q1 loss; announces acquisition, name and listing change (Investing.com)
Nov-04-25 04:05PM	Shoulder Innovations to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
Oct-21-25 08:07AM	Gold and silver miners tumble as precious metals retreat from record highs (Investing.com)
Oct-20-25 04:05PM	Shoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025 (PR Newswire)
Oct-14-25 02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat)
Sep-25-25 10:30AM	Aya Gold & Silver falls after short seller alleges resource inflation (Investing.com)
Sep-22-25 06:18AM	Shoulder Innovations Announces Full Commercial Launch of the InSet 70 Humeral Stem (PR Newswire)
Sep-09-25 07:00AM	Shoulder Innovations Reports Second Quarter 2025 Financial Results (PR Newswire) -5.79%
Sep-01-25 06:34AM	2 New IPOs on the Street Morgan Stanley Chooses the Superior Stock to Buy (TipRanks)
Aug-28-25 04:05PM	Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025 (PR Newswire) -6.09%
Aug-25-25 09:36AM	Figma initiated, Okta upgraded: Wall Street's top analyst calls (The Fly) +18.17%
Jul-31-25 08:55AM	NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO (PR Newswire)

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ball Robert Joseph	CEO & Executive Chairman	Feb 06 '26	Option Exercise	2.42	12,062	29,132	276,666	Feb 10 04:24 PM
Points Jeffrey S.	Chief Financial Officer	Dec 12 '25	Buy	14.98	1,005	15,055	54,445	Dec 15 04:57 PM
Points Jeffrey S.	Chief Financial Officer	Dec 11 '25	Buy	14.65	995	14,577	53,440	Dec 15 04:57 PM
Ball Robert Joseph	CEO & Executive Chairman	Dec 12 '25	Buy	14.89	3,900	58,075	118,457	Dec 15 04:51 PM
Ball Robert Joseph	CEO & Executive Chairman	Dec 11 '25	Buy	14.83	3,300	48,934	114,557	Dec 15 04:51 PM
Points Jeffrey S.	CHIEF FINANCIAL OFFICER	Sep 11 '25	Option Exercise	2.48	13,264	32,900	50,845	Sep 15 04:25 PM
Points Jeffrey S.	CHIEF FINANCIAL OFFICER	Sep 12 '25	Buy	15.67	1,600	25,072	52,445	Sep 15 04:25 PM
Blue David Lawrence	SEE REMARKS	Sep 12 '25	Option Exercise	2.16	94,394	204,135	138,331	Sep 15 04:21 PM
Ball Robert Joseph	CEO & EXECUTIVE CHAIRMAN	Sep 12 '25	Buy	15.49	6,000	92,945	111,259	Sep 15 04:15 PM
Ball Robert Joseph	CEO & EXECUTIVE CHAIRMAN	Sep 11 '25	Buy	14.90	2,000	29,810	105,259	Sep 15 04:15 PM
Ahearn Matthew Fraser	CHIEF OPERATING OFFICER	Sep 11 '25	Option Exercise	2.02	107,345	217,271	215,379	Sep 15 04:09 PM
Gilde Healthcare Holding B.V.	10% Owner	Aug 01 '25	Buy	15.00	100,000	1,500,000	2,380,482	Aug 05 06:37 PM
Carusi Michael A	Director	Aug 01 '25	Buy	15.00	266,666	3,999,990	1,885,136	Aug 05 04:05 PM
Buchholz Richard	Director	Aug 01 '25	Buy	15.00	5,000	75,000	12,666	Aug 05 04:05 PM
LSV Associates II, LLC	Former 10% Owner	Aug 01 '25	Buy	15.00	266,666	3,999,990	1,885,136	Aug 05 04:05 PM
Pardo Geoffrey B	Director	Aug 01 '25	Buy	15.00	100,000	1,500,000	2,380,482	Aug 05 04:05 PM
Tansey Casey M	Director	Aug 01 '25	Buy	15.00	40,000	600,000	47,666	Aug 05 04:05 PM
Points Jeffrey S.	CHIEF FINANCIAL OFFICER	Aug 01 '25	Buy	15.00	50	750	50	Aug 05 04:05 PM

SGP

SpyGlass Pharma Inc

SI

Shoulder Innovations Inc

Upgrade your FINVIZ experience